We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600848:SSEShanghai Lingang Holdings Corp. Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥10.51

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Shanghai Lingang Holdings trades around CNY 10.51, offering a trailing P/E of 16.9 versus an industry average of 32.8, suggesting a valuation cushion. However, the company’s revenue has contracted by 7.2% YoY and both operating and free cash flow are negative, highlighting cash generation concerns. The balance sheet shows a high debt load with a debt‑to‑equity ratio of 93.4%, while the dividend yield sits at a modest 1.9% and the payout ratio of 32% may be unsustainable given the cash shortfall. Technical signals are mixed: the 14‑day RSI at 33 points to oversold conditions, yet the MACD remains bearish and the price is hovering near its 20‑day SMA, indicating limited upside. Volatility is elevated at nearly 29% over the past month, but beta is low (0.18), implying limited market‑wide price swings. Support sits around CNY 10.42 with resistance near CNY 12, leaving little room for a strong rally without a catalyst.
Given the undervalued price relative to peers, the company could attract value‑oriented investors, but the combination of declining earnings, high leverage, and weak liquidity suggests caution. The decreasing volume trend and neutral overall trend direction further temper expectations for short‑term price appreciation. While the dividend provides a modest income stream, the negative cash flows raise doubts about its continuity. Investors should weigh the attractive valuation against the substantial financial and operational risks before committing capital.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Bearish MACD and decreasing volume
  • Oversold RSI suggesting limited upside
  • High debt and negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation discount relative to industry
  • Sustained revenue decline
  • Uncertain dividend sustainability

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation upside potential
  • Potential turnaround in cash flow if operations improve
  • Low beta indicating limited systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth-7.20%
Profit Margin14.55%
P/E Ratio17.0
ROE7.26%
ROA2.17%
Debt/Equity93.36
P/B Ratio1.4
Op. Cash FlowCN¥-1896278016
Free Cash FlowCN¥-1583154944
Industry P/E32.8

Technical Analysis

TrendNeutral
RSI33.0
SupportCN¥10.42
ResistanceCN¥12.00
MA 20CN¥11.06
MA 50CN¥11.54
MA 200CN¥10.55
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

GradeUndervalued
TypeValue
Dividend Yield1.90%

Risk Assessment

Beta0.18
Volatility28.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.